Contact this trialFirst, we need to learn more about you.
Antisense Oligonucleotide
Pelacarsen for Cardiovascular Disease
Recruiting1 awardPhase 3
Greensboro, North Carolina
This trial is testing a treatment to lower heart-related risks in patients who already have heart disease and high levels of a specific blood substance called Lp(a). Research is ongoing to find effective treatments for this condition.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service